Showing results (11-20 of 48) with videos related to
Sort By:
Pageof 5
Biopolymers|May 27, 2003
Dmt and opioid peptides: a potent allianceSharon D Bryant, Yunden Jinsmaa, Severo Salvadori, et al.Neuroscience Letters|March 28, 2014
Divalent metal ions enhance DOPAL-induced oligomerization of alpha-synucleinYunden Jinsmaa, Patricia Sullivan, Daniel Gross, et al.Chemical Research in Toxicology|July 22, 2014
Benomyl, aldehyde dehydrogenase, DOPAL, and the catecholaldehyde hypothesis for the pathogenesis of Parkinson's diseaseJohn E Casida, Breanna Ford, Yunden Jinsmaa, et al.The Journal of Pharmacology and Experimental Therapeutics|November 18, 2015
Comparison of Monoamine Oxidase Inhibitors in Decreasing Production of the Autotoxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde in PC12 CellsDavid S Goldstein, Yunden Jinsmaa, Patti Sullivan, et al.Parkinsonism & Related Disorders|July 31, 2016
Elevated cerebrospinal fluid ratios of cysteinyl-dopamine/3,4-dihydroxyphenylacetic acid in parkinsonian synucleinopathiesDavid S Goldstein, Courtney Holmes, Patricia Sullivan, et al.Neurochemical Research|May 26, 2016
3,4-Dihydroxyphenylethanol (Hydroxytyrosol) Mitigates the Increase in Spontaneous Oxidation of Dopamine During Monoamine Oxidase Inhibition in PC12 CellsDavid S Goldstein, Yunden Jinsmaa, Patti Sullivan, et al.Journal of Neurochemistry|February 4, 2015
Rotenone decreases intracellular aldehyde dehydrogenase activity: implications for the pathogenesis of Parkinson's diseaseDavid S Goldstein, Patti Sullivan, Adele Cooney, et al.Chemical Research in Toxicology|June 15, 2013
Cellular localization of dieldrin and structure-activity relationship of dieldrin analogues in dopaminergic cellsErin M G Allen, Virginia R Florang, Laurie L Davenport, et al.Chemical Research in Toxicology|April 25, 2009
Products of oxidative stress inhibit aldehyde oxidation and reduction pathways in dopamine catabolism yielding elevated levels of a reactive intermediateYunden Jinsmaa, Virginia R Florang, Jennifer N Rees, et al.The Journal of Pharmacology and Experimental Therapeutics|July 14, 2007
[N-allyl-Dmt1]-endomorphins are micro-opioid receptor antagonists lacking inverse agonist propertiesEwa D Marczak, Yunden Jinsmaa, Tingyou Li, et al.Pageof 5